ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00963495
Recruitment Status : Terminated
First Posted : August 21, 2009
Last Update Posted : June 22, 2015
Sponsor:
Information provided by (Responsible Party):
University Health Network, Toronto

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2013
  Actual Study Completion Date : September 2013